For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the emergence of Tafamidis and the formulated version represents a genuine advancement . These groundbreaking therapies protect the transthyretin protein, preventing its damaging build-up and reducing the severity of the disease . Individuals are now… Read More